Mammalian Target of Rapamycin: A New Molecular Target for Breast Cancer
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 4 (2) , 126-137
- https://doi.org/10.3816/cbc.2003.n.018
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- 4E-binding Proteins, the Suppressors of Eukaryotic Initiation Factor 4E, Are Down-regulated in Cells with Acquired or Intrinsic Resistance to RapamycinJournal of Biological Chemistry, 2002
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- The Hallmarks of CancerCell, 2000
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesionsNature Medicine, 1995
- HEAT repeats in the Huntington's disease proteinNature Genetics, 1995
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991